clinical trial · NCT06685835
A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)
Hidradenitis SuppurativaBrensocatibPlacebo
brief summary
The primary purpose of the study is to evaluate the effect of brensocatib compared with placebo.
started
Dec 16, 2024
primary completion
Feb 12, 2026
completion
Nov 17, 2026
last updated
Mar 6, 2026
official title
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa - The CEDAR Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol